Key Drivers
- Strong FY cash
- Q3 margin collapse
- Intangible‑heavy balance
AIAI Summary
ICON has shifted from a steady cash‑generative CRO to a higher‑volatility operational‑cleanup story where upside is now contingent on the Audit Committee producing no material restatement and the company delivering rapid stabilization of bookings/cancellations plus demonstrable margin recovery—investors should withhold re‑risking until clear audit outcomes and two quarters of improving cash conversion and cancellation trends.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong FY cash
- •Q3 margin collapse
- •Intangible‑heavy balance
ICLR delivered strong FY‑2024 cash generation and healthy historical margins but Q3‑2025 showed a sharp margin collapse, weakening liquidity, and an intangible‑heavy balance sheet that heighten near‑term risk.
Price Behavior
Key Price Behavior Insights:
- •Below SMA
- •Near support
- •~10% below highs
Short-term momentum is bearish with the stock trading below its last-month SMA and nearer recent support than resistance.
Price is ~10% below last month's high (110.60) yet only ~2.6% above last month's low, indicating compressed downside risk if support breaks
Sentiment & News
Key News Insights:
- •Concentrated litigation
- •Sharp share drop
- •Audit committee probe
Multiple law firms have launched coordinated securities-investigation solicitations into ICON plc following a single-day stock plunge and an Audit Committee probe, signaling sustained shareholder-litigation pressure and renewed scrutiny of ICON's fundamentals.
Heightened litigation risk and peer reassessment will likely increase volatility and sustain downward pressure on ICON's stock and disclosure scrutiny in the near term
Similar Companies in Healthcare
Other companies in the same sector with AI ratings